OGN Short Volume

Organon & Co. (OGN) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $3.50B, listed on NYSE, employing roughly 10,000 people, carrying a beta of 1.55 to the broader market. Organon & Co. Led by Joseph T. Morrissey Jr., public since 2021-05-14.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
739.6K
Total Volume
1.6M
Short %
46.11%
30-Day Avg Short %
43.56%

Showing 30 days of FINRA short volume data for Organon & Co..

Learn how short volume is reported and how to read the data →

OGN most-active contracts

TypeStrikeExpirationVolumeOIIVBidAsk
CALL$14.00Dec 18, 2026113.8K3.6%$0.10$0.15

Top 1 contracts from the ORATS-sourced nightly scan; ranked by volume within the broader S&P 500/400/600 + ETF universe.

Frequently asked OGN short volume questions

What is the daily OGN short volume?
As of May 15, 2026, Organon & Co. (OGN) short volume is 739.6K shares against 1.6M total reported volume, or 46.11% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is OGN short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does OGN short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.